港A特斯拉概念股集體上漲 特斯拉完成上海工廠產能擴大項目
格隆匯9月20日丨特斯拉概念股集體上漲,A股南玻A、廣東鴻圖、橫店東磁漲停,天齊鋰業漲8%,文燦股份、滬光股份漲7%;港股力勁科技漲6%,雅迪控股漲4%,億和控股、贛鋒鋰業、比亞迪股份漲3%。據上海企事業單位環境信息公開平台,特斯拉上海超級工廠(一期)第二階段的產線優化項目在9月1日竣工並開始調試,預計驗收期限為9月1日至11月30日。據瞭解,該項目投資總額高達12億元人民幣。此次的產線優化項目是特斯拉在現有工廠內進行擴建,主要通過提高生產節拍來擴大產能。另外,此前有消息稱特斯拉一直在提高產量以達到上海工廠每週生產約2.2萬輛Model 3和Model Y的目標。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.